|
ORC1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.22499999933146E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14820000016469E-07 |
| Normal-vs-Stage2 |
1.023870E-02 |
| Normal-vs-Stage3 |
1.30450000002114E-06 |
| Normal-vs-Stage4 |
8.36689999950124E-07 |
| Stage1-vs-Stage2 |
1.636370E-01 |
| Stage1-vs-Stage3 |
1.263760E-01 |
| Stage1-vs-Stage4 |
5.698800E-03 |
| Stage2-vs-Stage3 |
2.137900E-02 |
| Stage2-vs-Stage4 |
1.178810E-03 |
| Stage3-vs-Stage4 |
8.149700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.76939999716208E-08 |
| Normal-vs-AfricanAmerican |
2.499900E-03 |
| Normal-vs-Asian |
8.098400E-02 |
| Caucasian-vs-AfricanAmerican |
9.565700E-02 |
| Caucasian-vs-Asian |
3.119000E-01 |
| AfricanAmerican-vs-Asian |
2.135800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49510000047037E-07 |
| Normal-vs-Female |
8.94449999955249E-07 |
| Male-vs-Female |
9.466200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.960400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.09019999999993E-06 |
| Normal-vs-Age(61-80Yrs) |
2.34279999955511E-07 |
| Normal-vs-Age(81-100Yrs) |
2.564100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.035400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.271000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.834750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.023200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.997800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.131200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.165500E-02 |
| Normal-vs-Grade 2 |
1.13260000000892E-06 |
| Normal-vs-Grade 3 |
2.56340000004407E-06 |
| Normal-vs-Grade 4 |
7.50769999946499E-07 |
| Grade 1-vs-Grade 2 |
5.787600E-01 |
| Grade 1-vs-Grade 3 |
1.087370E-01 |
| Grade 1-vs-Grade 4 |
1.858850E-03 |
| Grade 2-vs-Grade 3 |
1.298610E-01 |
| Grade 2-vs-Grade 4 |
2.244200E-03 |
| Grade 3-vs-Grade 4 |
1.597710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.62619999999936E-05 |
| Normal-vs-ccB subtype |
7.34570000382462E-08 |
| ccA subtype-vs-ccB subtype |
4.218200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.88679999694131E-08 |
| Normal-vs-N1 |
3.551500E-04 |
| N0-vs-N1 |
1.198420E-03 |
|
|
